Combination therapy, utilizing Aromatase Inhibitors (AIs) alongside targeted agents, has emerged as one of the promising approaches in the treatment of hormone-sensitive breast cancer in postmenopausal

Breast cancer is commonly affecting cancer in women, and it is more common in postmenopausal women who have passed over 50 years of age. Even Though there are various advanced treatments involved in treating